GGrantIndex
Sort

166,118 grants matching stem cells

Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity

$2,020,212
James Alexander Thomson · Morgridge Institute For Research, Inc. · UH3 · FY2014 · TR

Molecular and Genomic Imaging Center

$2,020,168
George M Church · Harvard Medical School · P50 · FY2006 · HG

The Johns Hopkins Physical Sciences Oncology Center

$2,020,087
Denis Wirtz · Johns Hopkins University · U54 · FY2020 · CA

Molecular basis of T lineage specification

$2,019,751
David L Wiest · Research Inst Of Fox Chase Can Ctr · P01 · FY2020 · AI

Systematically mapping variant effects for cardiovascular genes

$2,019,687
Dan M Roden · Vanderbilt University Medical Center · R01 · FY2025 · HL

Targeted Sphingolipid Metabolism for Treatment of AML

$2,019,502
Thomas P Loughran · University Of Virginia · P01 · FY2016 · CA

Targeted Sphingolipid Metabolism for Treatment of AML

$2,019,502
Thomas P Loughran · University Of Virginia · P01 · FY2017 · CA

New Approaches to Dementia Heterogeneity

$2,019,359
Bruce L Miller · University Of California, San Francisco · P50 · FY2014 · AG

Mixed Hematopoietic Chimerism after Stem Cell Allografts

$2,019,270
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2006 · CA

Hematopoietic Chimerism after Stem Cell Allografts

$2,019,079
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA

Correlates of protective immunity to HCV and rational vaccine design

$2,018,828
Arash Grakoui · Emory University · U19 · FY2021 · AI

Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)

$2,018,750
Muralidhar L Hegde · Methodist Hospital Research Institute · RF1 · FY2020 · NS

Role of Pluripotency Factors in Embryonic Stem Cells, Development and Disease

$2,018,502
Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES

Improving the safety and efficacy of cell therapies

$2,018,471
Malcolm K Brenner · Baylor College Of Medicine · U54 · FY2008 · HL

Immune modulating therapies to treat complex regional pain syndrome

$2,018,200
Seena Ajit · Drexel University · RF1 · FY2022 · NS

New Approaches to Dementia Heterogeneity

$2,017,997
Bruce L Miller · University Of California, San Francisco · P50 · FY2016 · AG

Structure and function of eukaryotic DNA transposases

$2,017,907
Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

UNIV OF TX SOUTHWESTERN COMPREHENSIVE MED SICKLE CELL CT

$2,017,460
University Of Texas Sw Med Ctr/Dallas · U54 · FY2005 · HL

Neural Crest Development and Disease

$2,017,330
Laura Kerosuo · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE

Endothelial Cell Phenotypes in Health and Disease

$2,016,886
William C Aird · Beth Israel Deaconess Medical Center · P01 · FY2008 · HL

Molecular and Genomic Imaging Center

$2,016,675
George M Church · Harvard Medical School · P50 · FY2008 · HG

Center for Systematic Modeling of Cancer Development

$2,016,673
Stephen Tc Wong · Methodist Hospital Research Institute · U54 · FY2012 · CA

Novel Therapeutic Approaches for Parkinson's Disease

$2,016,348
Ole Isacson · Mclean Hospital · P50 · FY2008 · NS

Project 1

$2,015,880
Charles G. Mullighan · St. Jude Children'S Research Hospital · U54 · FY2019 · CA

DNA Repair, Mutations and Cellular Aging

$2,015,865
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · P01 · FY2020 · AG